The effect of sugammadex on the allergic component of rocuronium

Phase 4

• Conditions: Rocuronium allergy; Inflammatory and Immune System - Allergies

• Registration Number: ACTRN12610000707066
• Lead Sponsor: Sir Charles Gairdner Hospital

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2010-08-25
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: ot yet recruiting
• Sex: All
• Target Recruitment: 10

Inclusion Criteria

Previous allergy to rocuronium confirmed by skin testing

Exclusion Criteria

Lack of informed consent
Recent anti-histamine use
Skin infection of both arms (the site where the skin testing will occur)

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Whether or not a negative skin test results when sugammadex is combined with rocuronium in patients who are allergic to rocuronium[Skin test is read 20 minutes after drugs injected]

Secondary Outcome Measures

Name	Time	Method
nil[nil]